Investing.com - Adicet Bio (NASDAQ: ACET) reported third quarter EPS of $-1.16, $0.42 worse than the analyst estimate of $-0.74. Revenue for the quarter came in at $0.00 versus the consensus estimate of $1.11M.
Adicet Bio's stock price closed at $1.33. It is down -42.17% in the last 3 months and down -93.60% in the last 12 months.
Adicet Bio saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Adicet Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Adicet Bio's Financial Health score is "fair performance".
Check out Adicet Bio's recent earnings performance, and Adicet Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar